{"id":"https://openalex.org/W2007224588","doi":"https://doi.org/10.1159/000226374","title":"Quantitative Changes in Surface Immunoglobulin Expression in WEHI-231 Lymphoma Cells in Relation to Their Proliferative Rate","display_name":"Quantitative Changes in Surface Immunoglobulin Expression in WEHI-231 Lymphoma Cells in Relation to Their Proliferative Rate","publication_year":2009,"publication_date":"2009-06-23","ids":{"openalex":"https://openalex.org/W2007224588","doi":"https://doi.org/10.1159/000226374","mag":"2007224588","pmid":"https://pubmed.ncbi.nlm.nih.gov/3088507"},"language":"en","primary_location":{"id":"doi:10.1159/000226374","doi":"https://doi.org/10.1159/000226374","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000226374","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050697053","display_name":"Hamza Mujagi\u0107","orcid":"https://orcid.org/0000-0003-4986-1226","observed_orcids":["https://orcid.org/0000-0003-4986-1226"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"H. Mujagic","raw_affiliation_strings":["Clinical Pharmacology Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Md., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Md., USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027859218","display_name":"Stanley E. Shackney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210087180","display_name":"Allegheny-Singer Research Institute","ror":"https://ror.org/004315x41","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1310421338","https://openalex.org/I4210087180"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S.E. Shackney","raw_affiliation_strings":["Allegheny Singer Research Institute, Pittsburgh, Pa., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Allegheny Singer Research Institute, Pittsburgh, Pa., USA","institution_ids":["https://openalex.org/I4210087180"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000430633","display_name":"Carl E. Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C.E. Smith","raw_affiliation_strings":["Clinical Pharmacology Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Md., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Md., USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060931838","display_name":"Shan Shan Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shan Shan Chen","raw_affiliation_strings":["Clinical Pharmacology Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Md., USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Pharmacology Branch, Clinical Oncology Program, Division of Cancer Treatment, National Cancer Institute, National Institutes of Health, Bethesda, Md., USA","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.14705656,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"43","issue":"4","first_page":"237","last_page":"242"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.6176999807357788,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.6176999807357788,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.3407999873161316,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.012400000356137753,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/surface-immunoglobulin","display_name":"surface immunoglobulin","score":0.8489999771118164},{"id":"https://openalex.org/keywords/wehi-231-cells","display_name":"WEHI-231 cells","score":0.8970000147819519},{"id":"https://openalex.org/keywords/lymphoma","display_name":"lymphoma","score":0.6069999933242798},{"id":"https://openalex.org/keywords/cell-proliferation","display_name":"cell proliferation","score":0.9150000214576721},{"id":"https://openalex.org/keywords/cell-cycle","display_name":"cell cycle","score":0.47699999809265137},{"id":"https://openalex.org/keywords/dna-synthesis","display_name":"DNA synthesis","score":0.675000011920929},{"id":"https://openalex.org/keywords/rna-synthesis","display_name":"RNA synthesis","score":1.0},{"id":"https://openalex.org/keywords/igm","display_name":"IgM","score":0.5849999785423279},{"id":"https://openalex.org/keywords/kappa-light-chain","display_name":"kappa light chain","score":0.9810000061988831},{"id":"https://openalex.org/keywords/cell-size","display_name":"cell size","score":0.4650000035762787},{"id":"https://openalex.org/keywords/growth-phase","display_name":"growth phase","score":0.49000000953674316},{"id":"https://openalex.org/keywords/monoclonal-antibody-therapy","display_name":"monoclonal antibody therapy","score":0.8640000224113464},{"id":"https://openalex.org/keywords/lymphocyte-transformation","display_name":"lymphocyte transformation","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C2777108182","wikidata":"https://www.wikidata.org/wiki/Q422464","display_name":"Thymidine","level":3,"score":0.5988619327545166},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.5562211275100708},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5313875079154968},{"id":"https://openalex.org/C48900799","wikidata":"https://www.wikidata.org/wiki/Q1424376","display_name":"Doubling time","level":3,"score":0.529085636138916},{"id":"https://openalex.org/C553184892","wikidata":"https://www.wikidata.org/wiki/Q1141429","display_name":"Flow cytometry","level":2,"score":0.5289806127548218},{"id":"https://openalex.org/C2911212856","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Surface Immunoglobulin","level":4,"score":0.4891815483570099},{"id":"https://openalex.org/C64241487","wikidata":"https://www.wikidata.org/wiki/Q5205774","display_name":"DNA synthesis","level":3,"score":0.4755123257637024},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4639878273010254},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.40262308716773987},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.33770251274108887},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.3262422978878021},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.3033628463745117},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.2807875871658325},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.22820302844047546},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.21587395668029785},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.12020048499107361},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002455","descriptor_name":"Cell Division","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002460","descriptor_name":"Cell Line","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004273","descriptor_name":"DNA, Neoplasm","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D005434","descriptor_name":"Flow Cytometry","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D007145","descriptor_name":"Immunoglobulin kappa-Chains","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D007399","descriptor_name":"Interphase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D008223","descriptor_name":"Lymphoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008940","descriptor_name":"Mitotic Index","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011947","descriptor_name":"Receptors, Antigen, B-Cell","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D012334","descriptor_name":"RNA, Neoplasm","qualifier_ui":"Q000096","qualifier_name":"biosynthesis","is_major_topic":false},{"descriptor_ui":"D013936","descriptor_name":"Thymidine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014529","descriptor_name":"Uridine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1159/000226374","doi":"https://doi.org/10.1159/000226374","is_oa":false,"landing_page_url":"https://doi.org/10.1159/000226374","pdf_url":null,"source":{"id":"https://openalex.org/S198727964","display_name":"Oncology","issn_l":"0030-2414","issn":["0030-2414","1423-0232"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310317820","host_organization_name":"Karger Publishers","host_organization_lineage":["https://openalex.org/P4310317820"],"host_organization_lineage_names":["Karger Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"journal-article"},{"id":"pmid:3088507","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/3088507","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.5683000087738037,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2122562737","https://openalex.org/W1960436405","https://openalex.org/W2014200073","https://openalex.org/W2161169033","https://openalex.org/W2398252822","https://openalex.org/W1650411791","https://openalex.org/W1482151746","https://openalex.org/W2019487316","https://openalex.org/W1589414012","https://openalex.org/W1941870044"],"abstract_inverted_index":{"Quantitative":[0],"changes":[1,23,159],"in":[2,8,29,32,61,68,104,149,160,259],"surface":[3,165,199,239,257],"immunoglobulin":[4,170,200,258],"expression":[5,237,255],"were":[6,171,179,202],"studied":[7],"relation":[9],"to":[10,132,186,212],"the":[11,25,69,158,205,219],"proliferative":[12],"behavior":[13],"of":[14,27,46,71,99,115,134,207,221,224,230,238,256],"WEHI-231":[15],"cells.":[16],"They":[17],"undergo":[18],"morphologic,":[19],"biochemical":[20],"and":[21,35,41,91,106,126,128,167,192,194,216,232,246],"immunologic":[22],"during":[24,204],"course":[26],"growth":[28,53,244,251],"culture.":[30],"Changes":[31,148],"cell":[33,62],"size":[34],"morphology,":[36],"as":[37,39,152],"well":[38],"DNA":[40,231],"RNA":[42,144,233],"synthesis,":[43],"resemble":[44],"features":[45],"normal":[47],"lymphocyte":[48],"transformation.":[49],"During":[50],"log":[51,76,210],"phase":[52,77,85,211,214],"there":[54],"was":[55,81,86,241],"a":[56,65],"more":[57],"than":[58],"30-fold":[59],"increase":[60],"number":[63],"over":[64],"4-day":[66],"period":[67],"absence":[70],"medium":[72],"change.":[73],"The":[74,253],"average":[75],"population":[78],"doubling":[79],"time":[80],"20":[82],"h.":[83],"Plateau":[84],"achieved":[87],"on":[88,123,137,189],"day":[89,94,138],"5,":[90],"maintained":[92],"through":[93],"7.":[95],"Image":[96],"analysis":[97],"studies":[98],"cytocentrifuged":[100],"cells":[101,208,226,263],"demonstrated":[102],"increases":[103],"cell,":[105],"nuclear":[107],"area":[108],"that":[109],"became":[110],"apparent":[111],"within":[112],"2":[113,125],"h":[114],"transplantation.":[116],"Tritiated":[117,140],"thymidine":[118,162],"incorporation":[119,142],"rose":[120,182],"rapidly":[121,185],"peaking":[122],"days":[124,190],"3,":[127],"then":[129,195],"fell":[130,196],"progressively":[131],"35%":[133],"peak":[135,187],"values":[136,178,188],"4.":[139],"uridine":[141],"into":[143],"showed":[145],"similar":[146],"changes.":[147],"S":[150],"fraction,":[151],"determined":[153],"by":[154,174],"flow":[155,175],"cytometry,":[156],"paralleled":[157],"tritiated":[161],"incorporation.":[163],"Cell":[164],"IgM":[166],"kappa":[168],"light-chain":[169],"also":[172],"measured":[173],"cytometry.":[176],"Mean":[177],"low":[180,228],"initially,":[181],"slowly,":[183],"increased":[184],"3":[191],"4,":[193],"progressively.":[197],"Peak":[198],"levels":[201],"observed":[203],"transition":[206],"from":[209],"plateau":[213],"growth,":[215],"coincided":[217],"with":[218,227,243,248,270],"appearance":[220],"large":[222],"numbers":[223],"small":[225,260],"rates":[229],"synthesis.":[234],"Thus,":[235],"maximum":[236],"Ig":[240],"associated":[242],"retardation,":[245],"not":[247],"early":[249],"rapid":[250],"phase.":[252],"maximal":[254],"slowly":[261],"proliferating":[262],"may":[264],"have":[265],"important":[266],"implications":[267],"for":[268],"immunotherapy":[269],"monoclonal":[271],"antibodies":[272],"alone.":[273]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}